bexarotene
bexarotene: 2 clinical trials tracked.
bexarotene evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
What is verified about bexarotene, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (2)
Metastatic Triple-Negative Taxane-Resistant Breast Cancer: Investigating the Role of Bexarotene in Inducing Susceptibility to Chemotherapy by Differentiating Cancer Cells From a Mesenchymal-Like to an Epithelial-Like Phenotype
Primary endpoint: Tumour transcriptome by RNA sequencing
A Phase I/II Study of Bexarotene in Combination With ZD 1839 (IRESSA) in the Third Line Treatment of Non-Small Cell Lung Cancer (NSCLC)
Primary endpoint: Overall response rate (RECIST CRITERIA), time to progression, toxicity